Preserving the Promise:
Improving the Culture of Biotech Investment
Written by an Angel investor and a Biotech founder, Preserving the Promise examines why so many important medical discoveries never reach the clinic, and offers practical alternatives for improving the development process:
Explains why translation of biotech discovery into medicine succeeds so infrequently that it’s been dubbed the Valley of Death.
- Uncovers specific decision-making strategies that more effectively align incentives, improving clinical and financial outcomes for investors, inventor/entrepreneurs, and patients.
- Examines the critical, early stages of commercialization, where technology transfer offices and Angels act as gatekeepers to development, and where tension between short-term financial and long-term clinical aspirations sinks important technologies.
- Deconstructs the forces driving biotech, recasts them in a proven conceptual framework, and offers practical guidance for making the system better.
Written for Entrepreneurs, Angels and seed-stage investors, technology transfer officers, academic researchers, pharma/biotech and med device professionals, business developers, economic development and public policy specialists, and all others with a professional or personal stake in human health.
Preserving the Promise offers a unique, original perspective on how to succeed in getting new drugs and therapies to the clinic.